The phenotypic profile of gluten-specific CD4+ T cells changes in patients with CeD while on a GFD but rapidly reverses to that observed in patients with untreated CeD upon gluten re-exposure [80]. This evidence concerns the gene CD4 and cranioectodermal dysplasia.